First described in 1961, photoonycholysis (PO) is a rare nail alteration that may result from drug intake, from topical aminolevulinate photodynamic therapy or from photosensitive conditions such as porphyria or pseudoporphyria. Spontaneous PO is rare. This review updates the numerous causes of PO and highlights some new ways producing this condition. Four different types of PO are clearly recognized without relationship with the responsible drug. An updated list of potential inducing drug is provided. Some practical points on PO have been raised. The inability to reproduce photoonycholysis experimentally should be emphasized, and the pathogenesis of PO still needs to be clarified.
Introduction
First described by Orentreich in 1961, 1 photoonycholysis is a rare nail alteration that may result from drug intake, from topical aminolevulinate photodynamic therapy or in photosensitive conditions such as porphyria or pseudoporphyria. Spontaneous photoonycholysis is rare.
Drug-induced photoonycholysis
Photoonycholysis is a possible side-effect of cutaneous phototoxic reactions that occasionally complicate therapy with tetracycline compounds, psoralens and fluoroquinolones (Table 1) . [2] [3] [4] It usually appears more than 2 weeks after exposure to the drug and often follows a photosensitivity reaction in the skin. It may be initially observed as a part of Segal's triad -photosensitivity followed by discoloration of the nails and onycholysis. 5 The time between the onset of photoonycholysis and the previously exaggerated sunburn reaction may vary from 3 to 6 weeks. Onycholysis can also appear in the absence of any previous photosensitive reaction elsewhere. 6, 7 Onychodynia may precede 1-4-week onycholysis. 8 Several drugs are able to cause photoonycholysis but, as yet, pain has mainly been described with tetracyclines and psoralens plus ultraviolet A (PUVA). 9 The mechanism of pain is unknown, but terminal vessels, capillaries or glomus bodies may probably play an important role.
Clinical manifestations
Four distinct varieties of onycholysis have been noted after drug intake and one common sign was prevalent in the first three types: the lateral margins of the nails were unaffected. It is interesting to note that there is no apparent relationship between the responsible drugs and the different types of photoonycholysis. Type I: Several fingers are involved. The separating part of the nail plate is half-moon-shaped and distally concave with a variable pigmentation degree and well-demarcated proximal border (Fig. 1a,b) .
Type II: A well-defined circular notch distally opened presents with a proximal brownish hue and is restricted to only one finger (Fig. 2) .
Type III: There is initially a round yellow staining that turns reddish after 5-10 days involving the central part of the pink nail bed of several fingers (Fig. 3) .
Type IV: Blisters under the nails have rarely been reported in photoonycholysis due to tetracycline hydrochloride 7 and in porphyria cutanea tarda 10 ( Fig. 4) , congenital erythropoietic porphyria, 11 erythropoietic protoporphyria, 12 variegate porphyria as well as in pseudoporphyria. 13, 14 Such a classification of onycholysis into four subtypes is justified by the different features of the lesions. The round or oval spot of the central nail bed of type III shows the link between photoonycholysis and subungual photohaemorrhage ( that may sometimes appear straight away, involving all nails or some of them. Sometimes splinter haemorrhages can be observed. The latter usually appear to be a sequela of photoonycholysis, depending on the timing, but may also occur primarily non-associated to photoonycholysis.
Nail discoloration
The origin of the discoloration observed in most patients is not clear. It could be caused by blood extravasation and/or by subungual keratin dust. Thus, splinter haemorrhages that have been reported with onycholysis after tetracycline, and haemosiderin deposits should be considered in cases with a brown-yellow discoloration. Using light and electron microscopy, Zala et al. 15 studied a patient who developed photoonycholysis after 8-methoxypsoralen treatment. They observed abundant erythrocytes on the surface of the toenail bed and appearance of numerous multinucleate epithelial cells and fibroblasts. However, multinucleate cells in the nail bed are not an exceptional finding. They have been reported in Darier's disease as well as in subungual onychopapilloma, even in serial sections. 16, 17 Histologic examination in five of our patients (two with type I, others with type II and one with type III) showed only slight vasodilation because the biopsy specimens were taken at the first visit and a purpuric reaction could have appeared later, as we have seen in some of our patients. Iron stain was negative. Keratin dust can also cause dyschromia as a result of discrete subungual hyperkeratosis or exogenous material. 2 This was evident in one of our patients in whom such material was removed at a later visit.
Mechanism
Shuster considered photoonycholysis to be an analogue of sunburn peeling. 18 In miliaria, the zone of dehiscence in UVdamaged epidermal cells is moved up when new epidermal cells are formed after 5-7 days causing a disruption of the sweat duct and leakage of sweat forming a blister. It is believed that the nail acts as a convex lens, focusing the UVA rays onto the nail. 3 The sparsity of melanin, the absence of sebaceous glands and relative lack of stratum granulosum have all been suggested to play a role in favouring ultraviolet penetration in the nail bed. 3 Whilst the human nail transmits 20% short wavelengths of light poorly, thus blocking 97% of UVB radiation (280-320 nm), it allows 10% transmission of UVA (320-400 nm). 4, 19 As the nail is formed continuously along its length and not only in the matrix, the UV damage caused dehiscence and separated the nail from its active site of growth in the bed. Notably, photoonycholysis is likely to result principally from drugs such as tetracyclines whose molecular structures have wavelengths between 290 and 320 nm in contrast to the psoralen whose wavelengths lie in the UVA band. In the case of porphyrias, the deleterious wavelengths are 400-410 mm, the so-called Soret's band.
Topical aminolevulinate photodynamic therapy
To our knowledge, two cases of photoonycholysis have been reported after photodynamic therapy (PDT). The first, a 53-year-old woman, was treated for actinic keratoses (AKs) on the dorsum of the hands and fingers. 20 Four hours after photoocclusion, the lesions were irradiated with 37 J/cm 2 of red light (634 nm). Because the AKs were localized close to the nails, the ALA cream reached the ventral-free edge of the third nail of the right hand subsequently also irradiated. The PDT was very painful especially on an accidentally affected nail and the pain lasted for 1 week followed by only partial remission of the photoonycholysis and complete remission after 3 months. The second case, a 65-year-old woman, was treated for AKs of the perioral region with PDT. 21 Aminolevulinic acid hydrochloride 20% was applied to the lips and allowed to incubate for 60 min. Her face was irradiated with 5/cm 2 of blue light (417 nm) for 16 min and 40 s. Sunscreen was applied to the area immediately after treatment. Within 72 h following treatment, the patient reported all 10 fingernails to be noticeably separated from the nail bed with minimal pain, corresponding to type I photoonycholysis. According to the authors' hypothesis, the patient touched her face with her fingernails during the 60-min incubation time prior to ALA-PDT treatment under blue light, involuntarily containing ALA under her fingernails. 
Porphyrias
The porphyrias are a group of diseases characterized by genetic or acquired enzyme deficiencies in the metabolic pathway of haem, resulting in accumulation of haem precursors: 5-delta-aminolevulinic acid (ALA), porphobilinogen (PBG) and/or porphyrins (P). Based on clinical manifestations, it is possible to divide the porphyrias into three categories:
• Cutaneous porphyrias with a) acute phototoxic responses (acute cutaneous syndrome).
• Acute porphyrias and particularly acute intermittent porphyria (AIP) are characterized by acute abdominal and neurological attacks with neither cutaneous manifestations nor nail alterations. In fact the exceptional cases in which photo-onycholysis has been attributed to the AIP we may presume that, in fact, they were unrecognized forms of mixed porphyria (porphyria variegata) or due to the association of two different types of porphyria (dual porphyria: DP) because the excess of porphyrin precursors characteristic of AIP does not produce photosensitivity and without special studies it is not possibly to identify PV or DP.
• Mixed porphyrias (porphyria variegata -PV and hereditary coproporphyria -HCP) may produce both acute attacks and/or cutaneous lesions.
Clinical manifestations
Cutaneous porphyrias Dermatological manifestations of cutaneous porphyrias appear in two different forms:
• An acute syndrome of photosensitivity with cutaneous lesions resembling sunburn, due to sunlight exposure or, less commonly, to artificial light sources (particularly to the 400-410 nm wavelengths, Soret's band). This is very characteristic of EPP, in which there is an overproduction of protoporphyrin. However, acute photosensitivity may also develop in homozygous porphyrias when overproduction of hydrophilic porphyrins is extremely high as it happens in CEP and HEP.
• A subacute syndrome of cutaneous hyperfragility with vesiculobullous and erosive lesions developing after minimal trauma. This symptom is the characteristic of porphyrias with overproduction of hydrophilic porphyrins: PCT, CEP and HEP and of mixed porphyrias: PV and HCP.
Porphyria cutanea tarda. PCT, due to uroporphyrinogen decarboxylase (UPD) deficiency, is divided into four distinct clinical types. PCT type I is a sporadic variant that develops in adults with no familial or inherited background; PCT types II and III are familial and may appear in children; UPD deficiency may be expressed in all tissues (type II) or may be absent in erythrocytes (type III). PCT type IV is toxic porphyria, and the best-known responsible toxic agent is hexachlorobenzene. In spite of these differences, clinical manifestations are identical in all forms. Skin hyperfragility is usually the first clinical manifestation (Fig. 6) . Small serous or haemorrhagic vesicles or blisters after minimal trauma, less frequently sun induced, develop most commonly on the dorsum of hands. Disappearance of the lunula, onycholysis and onychodystrophy may also appear, but photoonycholysis is very uncommon. 22 Patients also present facial and limb hypertrichosis. Liver involvement is found in most PCT I; however, cirrhosis is uncommon. Hepatitis C virus infection (antibodies are present in 89% of sporadic PCT 23 patients but absent in familial PCT) may, as well as HIV infection, trigger the disease. 24 The urine is dark brown and red fluorescent under Wood's light due to its porphyrin content. The most abundant porphyrin in urine is uroporphyrin (UP) followed by 7-carboxylic porphyrin (7-COOH). In faeces, the presence of a 5-carboxylic porphyrin named iso-coproporphyrin (iso-CP) is very characteristic.
Erythropoietic protoporphyria. After PCT, EPP due to ferrochelatase (FeCh) deficiency is the most common variety of porphyria. Autosomal-dominant inheritance with variable expressivity and incomplete penetrance has been considered; however, heredity is complex and to develop EPP it appears that the patient must have inherited the deficiency from a biochemically abnormal asymptomatic relative and, also, a variant of FeCh (that 10% of population carries) with reduced expression of the gene. 25, 26 The primary cutaneous manifestation is increased photosensitivity. Usually, visible manifestations are preceded by itching, a burning sensation or pain. Subjective manifestations may be mild or severe and cause crying. Erythema, oedema and even purpura (similar to severe sunburn) may appear on sun-exposed areas. Symptoms may also develop following exposure to artificial light. Shaded facial areas are usually spared. Acute light-induced manifestations may also develop in the dorsal periungueal area of fingers. Nail alterations are not very common, but mild-to-moderate nail plate dystrophies and photoonycholysis may appear if sun exposure is not avoided.
Defective FeCh is responsible for PP overproduction. However, as PP is lipophilic but non-hydrophilic, urinary porphyrin levels are normal but raised in plasma, erythroblasts and erythrocytes with a transient fluorescent under Wood's light due to the rapid transformation of PP in non-fluorescent oxyporphyrin.
Photoprotection is really important in EPP. Common sunscreen protects from sunburn band (290-320 nm) but not from longer wavelengths (400-410 nm or even longer), particularly harmful for EPP patients. Physical sunscreens are more useful. A coloured nail lacquer could be helpful to protect nails and prevent photoonycholysis. Systemic betacarotene (120-80 mg daily; 15-90 mg daily for children) usually permits patients a relative outdoor light tolerance.
Homozygous porphyrias. There is a group of porphyrias in which homozygous expression of their enzymatic deficiency produces severe disease. Two forms of homozygous porphyrias are of special interest.
Congenital erythropoietic porphyria-CEP or G€ unther disease due to uroporphyrinogen III cosynthase (UPIII-S) deficiency is a rare severe recessive disease characterized by cutaneous hyperfragility and photosensitivity, initially similar to PCT. Urine is dark and fluorescent. However, in CEP, the deciduous teeth are dark red in colour (erythrodontia) and red fluorescent due to porphyrin deposition. Hypertrichosis is constant on the light-exposed skin. Evolution of the disease is marked by its gradual mutilating tendency. And successive blistering episodes produce scars and severe mutilations of the centrofacial area as well as of the hands. Sclerodactyly, nail dystrophy and eventually photoonycholysis develop on the hands, with progressive loss of the terminal phalanges and finger nails. Toenails are almost always protected by socks and shoes. Fingers and nails could be protected by continuous use of gloves. Erythrocytes and bone marrow erythroblasts show strong persistent red fluorescence upon exposure to Wood's light as they contain large amounts of isomer I porphyrins. Mildto-severe haemolytic anaemia and progressive splenomegaly are common.
Hepatoerythropoietic porphyria-HEP is a rare autosomal-recessive disease that presents in infancy, with manifestations identical to those of CEP. However, erythrodontia, haemolytic anaemia and splenomegaly do not occur. Finger nails present identical modifications as in CEP, from mild dystrophy or photoonycholysis to complete disappearance of the distal phalanx; toe nails are also preserved due to socks and shoe wearing. The biochemical pattern is identical to PCT because HEP is the homozygous or double heterozygous form of familial PCT types II and III. 27 In all homozygous porphyrias (CEP and HEP), it is crucial to protect patients, particularly children, from trauma, even minimal but reiterated, and from sunlight. This is principally important for hands as feet are protected by socks and shoes.
Pseudoporphyrias
The term pseudoporphyria (PSP) has been used for patients presenting symptomatological manifestations that clinically look similar to those of true porphyrias (in general they mimic PCT) but that are not due to any enzyme deficiency of the haem pathway. 28 Most cases are in fact drug-induced phototoxic reactions (Table 2 ). There is also another type of pseudoporphyria that may appear in patients who suffer chronic renal insufficiency when haemodialysis is unable to remove plasma porphyrins and hyperporphyrinemia (HP), not due to any enzyme deficiency, occurs. There is also the possibility of chronic renal insufficiency in a patient suffering PCT; in that case, there is a typical PCT porphyrin excretion pattern (uro-and heptacarboxylic porphyrins in urine and iso-coproporphyrin in stool) permitting to identify that suffer a true PCT, but haemodialysis is unable to remove excessive porphyrins). All patients with hyperporphyrinemia (PSP or PCT plus HP) may present identical cutaneous lesions as in PCT, but as in that one, photoonycholysis is uncommon.
Spontaneous photoonycholysis
Four of the six recorded patients with spontaneous photoonycholysis were Caucasian men, 29, 30 one was a West Indian, and the last one was a Japanese woman. 31 Scarce melanin in the nail bed of Caucasians is commonly present. A recent melanocyte count for the nail bed epithelium has shown that it ranged from 0 to 5 with a mean of 0.43. The melanocytes were restricted to the basal layer with thin cytoplastic dendrites. 32 We have therefore postulated that the absence or rareness of spontaneous photoonycholysis in people with darker skin types is due to presence of melanin, providing some degree of natural photoprotection to the nail bed. However, paradoxically the incidence of photoonycholysis has been higher in darkly pigmented individuals on benoxaprofen whose pigmentation has allowed them to get regular exposure to sunlight. 33 Nevertheless, our enquiries at a number of American universities dealing predominantly with African Americans suggest that drug-induced photoonycholysis was not recognized as a problem perhaps because the melanosomes of these subjects have a protective effect, as variations in racial pigmentation are due to the number and size of melanosomes produced. Moreover, in Caucasians a few melanosomes are of the melanized type IV (opaque to electrons) although in non-Caucasians they are abundant before irradiation. However, we have observed a phototype V West Indian male patient with spontaneous photoonycholysis whose presenting symptom was subungual pain 34 similar to the cases observed by tetracycline derivatives or PUVA therapy. Biopsy showed large areas of subungual tissue lacking a protective melanin shield against solar radiation. Under electron microscopy, a mosaic of melanocytes of Negroid and Caucasian type in the melanocyte unit was observed. The patient was phenotypically a mixed type. The alternation of smaller melanin columns and larger melanin-free spaces in the surface layers could be the reason for the absence of a sufficient photoprotection by melanin. 35 In addition, recently a case of hypopigmented mycosis fungoides was reported in a 16-year-old male patient with skin type VI presenting onycholysis preceded by onychodynia, 3 weeks after completing 29 sessions of PUVA. 36 The authors speculated that this may be due to a decrease in melanocytes in hypopigmented skin.
Discussion
The usual inability to reproduce photoonycholysis experimentally with a single irradiation dose should be emphasized. Light from a monochromator emitting 'narrow' band wavelengths (313-500 nm) could penetrate a 0.7-mm-thick finger nail from 3 to 20 percent. 2 In 3 patients treated with 1 g tetracycline daily for 1-4 weeks, the authors were unable to induce onycholysis with single dose of 313 nm (2 J/cm 2 ) or 360 nm (10 J/cm 2 ). 34 Nor could it be reproduced in our West Indian patient with UV-B 150 mJ/m 2 or UV-A 4 60 J/cm 2 , despite his spontaneous relapse of onycholysis with haemorrhagic discoloration every July since his arrival in France, associated with a recurrence every December when he returned to his native Martinique.
34,35

Conclusion
Several reports of photoonycholysis due to new drugs have been published since our previous papers on this topic 4 but the mechanism of this phenomenon has not yet been clarified.
